Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow

Stem Cells

Volumn 25, Issue 10, 2007, Pages 2511-2523

  Tsai, Ming Song ^a,b   Hwang, Shiaw Min ^c   Chen, Kuang Den ^d   Lee, Yun Shien ^e,f   Hsu, Li Wen ^c   Chang, Yu Jen ^c   Wang, Chao Nin ^f   Peng, Hsiu Huei ^f   Chang, Yao Lung ^f   Chao, An Shine ^f   Chang, Shuenn Dyh ^f   Lee, Kuan Der ^g   Wang, Tzu Hao ^f,h   Wang, Hsin Shih ^d,f   Soong, Yung Kuei ^f  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e MING CHUAN UNIVERSITY   (Taiwan)

^f Lin Kou Medical Center   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Functional network analysis; Mesenchymal stem cells; Microarray; Transcriptome

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRADYKININ RECEPTOR; ELECTROLYTE; ENDOTHELIN; MEMBRANE METALLOENDOPEPTIDASE; OXYTOCIN; THROMBIN RECEPTOR; TRANSCRIPTOME;

AMNION; AMNION FLUID; ARTICLE; BONE MARROW; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MESENCHYMAL STEM CELL; OSSIFICATION; PATHOGENESIS; UMBILICAL CORD BLOOD; UPREGULATION;

AMNION; AMNIOTIC FLUID; BONE MARROW CELLS; CELL LINEAGE; CELLS, CULTURED; FEMALE; FETAL BLOOD; FETAL PROTEINS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PREGNANCY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UTERUS; WATER-ELECTROLYTE BALANCE;

EID: 35348861286     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0023     Document Type: Article

References (70)

1. Mannello F, Tonti GAM, Bagnara GP et al. Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. STEM CELLS 2006;24:475-481.
2. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-856.
3. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 2003;100:11917-11923.
4. Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119:2204-2213.
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
6. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
7. Xu Y, Malladi P, Wagner DR et al. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 2005;7:300-305.
8. Bieback K, Kern S, Kluter H et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. STEM CELLS 2004;22:625-634.
9. Tsai MS, Lee JL, Chang YJ et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004;19:1450-1456.
10. Tsai MS, Hwang SM, Tsai YL et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006;74:545-551.
11. Zhao P, Ise H, Hongo M et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005;79:528-535.
12. Ochsenbein-Kolble N, Bilic G, Hall H et al. Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair. J Perinat Med 2003;31:287-294.
13. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 2004;22:1338-1345.
14. Portmann-Lanz CB, Schoeberlein A, Huber A et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006;194:664-673.
15. Kim JW, Kim SY, Park SY et al. Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol 2004;83:733-738.
16. Fu YS, Cheng YC, Lin MY et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. STEM CELLS 2006;24:115-124.
17. Bianco P, Riminucci M, Gronthos S et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. STEM CELLS 2001;19:180-192.
18. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. STEM CELLS 2004;22:487-500.
19. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-316.
20. Lee OK, Kuo TK, Chen WM et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675.
21. Jeong JA, Hong SH, Gang EJ et al. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. STEM CELLS 2005;23:584-593.
22. Phinney DG, Hill K, Michelson C et al. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. STEM CELLS 2006;24:186-198.
23. Aiba K, Sharov AA, Carter MG et al. Defining a developmental path to neural fate by global expression profiling of mouse embryonic stem cells and adult neural stem/progenitor cells. STEM CELLS 2006;24:889-895.
24. Jaatinen T, Hemmoranta H, Hautaniemi S et al. Global gene expression profile of human cord blood-derived CD133+ cells. STEM CELLS 2006;24:631-641.
25. Chang YJ, Shih DT, Tseng CP et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. STEM CELLS 2006;24:679-685.
26. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
27. Wang TH, Lee YS, Chen ES et al. Establishment of cDNA microarray analysis at the Genomic Medicine Research Core Laboratory (GMRCL) of Chang Gung Memorial Hospital. Chang Gung Med J 2004;27:243-260.
28. Lee YS, Chen CH, Chao A et al. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132.
29. Chao A, Wang TH, Lee YS et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006;119:91-98.
30. Wang TH, Chan YH, Chen CW et al. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene 2006;25:4857-4866.
31. Nikolsky Y, Ekins S, Nikolskaya T et al. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20 -29.
32. Mason CW, Swaan PW, Weiner CP. Identification of interactive gene networks: A novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 2006;194:1513-1523.
33. Shi L, Reid LH, Jones WD et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24:1151-1161.
34. Canales RD, Luo Y, Willey JC et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006;24:1115-1122.
35. Guo L, Lobenhofer EK, Wang C et al. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 2006;24:1162-1169.
36. Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. STEM CELLS 2006;24:376-385.
37. Elovitz MA, Ascher-Landsberg J, Saunders T et al. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol 2000;183:674-681.
38. Casey ML, Word RA, MacDonald PC. Endothelin-1 gene expression and regulation of endothelin mRNA and protein biosynthesis in avascular human amnion. Potential source of amniotic fluid endothelin. J Biol Chem 1991;266:5762-5768.
39. Marvin KW, Keelan JA, Eykholt RL et al. Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua. Am J Obstet Gynecol 2002;187:728-734.
40. Fried G, Sand A, Ostlund E et al. Endothelin-1 and macrophage colony-stimulating factor are co-localized in human amnion membrane cells and secreted into amniotic fluid. Mol Hum Reprod 2003;9:719-724.
41. Prabhakar SS. Regulatory and functional interaction of vasoactive factors in the kidney and extracellular pH. Kidney Int 2004;66:1742-1754.
42. Quaschning T, Galle J, Wanner C. Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Kidney Int Suppl 2003:S54-57.
43. Fiore G, Florio P, Micheli L et al. Endothelin-1 triggers placental oxidative stress pathways: Putative role in preeclampsia. J Clin Endocrinol Metab 2005;90:4205-4210.
44. LaMarca BB, Cockrell K, Sullivan E et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005;46:82-86.
45. Morgan R. Hox genes: A continuation of embryonic patterning? Trends Genet 2006;22:67-69. Epub 2005 Dec 2001.
46. Walsh MC, Kim N, Kadono Y et al. Osteoimmunology: Interplay between the immune system and bone metabolism. Annu Rev Immunol 2006;24:33-63.
47. Rice CM, Scolding NJ. Adult stem cells - Reprogramming neurological repair? Lancet 2004;364:193-199.
48. Bastelica D, Morange P, Berthet B et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: Evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002;22:173-178.
49. Alviano F, Fossati V, Marchionni C et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007;7:11.
50. Gronthos S, Franklin DM, Leddy HA et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001;189:54-63.
51. Panepucci RA, Siufi JL, Silva WA Jr et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. STEM CELLS 2004;22:1263-1278.
52. Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A 1980;77:4756-4759.
53. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 1996;383:441-443.
54. Okumura Y, Kamikubo Y, Curriden SA et al. Kinetic analysis of the interaction between vitronectin and the urokinase receptor. J Biol Chem 2002;277:9395-9404.
55. Czekay RP, Aertgeerts K, Curriden SA et al. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 2003;160:781-791.
56. Ruscetti FW, Akel S, Bartelmez SH. Autocrine transforming growth factor-beta regulation of hematopoiesis: Many outcomes that depend on the context. Oncogene 2005;24:5751-5763.
57. Zhu H, Mitsuhashi N, Klein A et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. STEM CELLS 2006;24:928-935.
58. Krause DS, Lazarides K, von Andrian UH et al. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006;24:24.
59. Jin L, Hope KJ, Zhai Q et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006;24:24.
60. Yauk CL, Berndt ML, Williams A et al. Comprehensive comparison of six microarray technologies. Nucleic Acids Res 2004;32:e124.
61. Carter SL, Eklund AC, Mecham BH et al. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics 2005;6:107.
62. Wang H, He X, Band M et al. A study of inter-lab and inter-platform agreement of DNA microarray data. BMC Genomics 2005;6:71.
63. Degryse B, Neels JG, Czekay RP et al. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J Biol Chem 2004;279:22595-22604.
64. Gao R, Brigstock DR. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003;27:214-220.
65. Zilberberg A, Yaniv A, Gazit A. The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway J Biol Chem 2004;279:17535-17542.
66. Si W, Kang Q, Luu HH et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006;26:2955-2964.
67. Maki JM, Sormunen R, Lippo S et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 2005;167:927-936.
68. Miyata T, Iizasa H, Sai Y et al. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 2005;204:948-955.
69. Shields JM, Rogers-Graham K, Der CJ. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem 2002;277:9790-9799.
70. Pelham HR. The dynamic organisation of the secretory pathway. Cell Struct Funct 1996;21:413-419.